ATI RN
CNS Drugs Pharmacology PDF Questions
Question 1 of 5
Regarding nondepolarising muscle relaxants, which statement is true?
Correct Answer: A
Rationale: The correct answer is A) Jaw and eye muscles are paralyzed before the limb and trunk muscles. This statement is true because nondepolarizing muscle relaxants typically exhibit a pattern of paralysis starting from small muscles to larger muscles. This phenomenon is known as the "cephalocaudal" progression of muscle paralysis, where muscles closer to the head are affected before those further away. Option B) Rocuronium is the most potent relaxant is incorrect. While rocuronium is a commonly used nondepolarizing muscle relaxant, it is not the most potent. Potency can be measured by factors such as the dose required to achieve a certain level of muscle relaxation. Option C) Atracurium is a steroid derivative is incorrect. Atracurium is actually a benzylisoquinolinium nondepolarizing muscle relaxant, not a steroid derivative. Understanding the chemical structure and classification of drugs is important in pharmacology. Option D) Vecuronium blocks cardiac muscarinic receptors thus inducing a moderate increase in heart rate is incorrect. Vecuronium is a nondepolarizing muscle relaxant that does not have significant effects on cardiac muscarinic receptors. It is important for healthcare professionals to have accurate knowledge of the pharmacological effects of muscle relaxants to ensure safe and effective patient care. Educationally, understanding the mechanism of action and specific characteristics of different muscle relaxants is crucial for healthcare professionals involved in anesthesia and critical care settings. This knowledge helps in selecting the most appropriate drug for a specific patient, monitoring for potential side effects, and managing complications that may arise during the administration of these medications.
Question 2 of 5
A 62-year-old retired small business owner has had slowly increasing intraocular pressure bilaterally. You start him on drug used to treat his open-angle glaucoma, which also happens to cross the blood–brain barrier better than other drugs in its class. Which of the following drugs is this?
Correct Answer: D
Rationale: The correct answer is D) Physostigmine. Physostigmine is a cholinesterase inhibitor that is used to treat open-angle glaucoma due to its ability to cross the blood-brain barrier more effectively compared to other drugs in its class. This property allows physostigmine to exert its pharmacological effects centrally as well as peripherally, making it a more potent option for treating conditions like glaucoma. A) Echothiophate is also a cholinesterase inhibitor used in the treatment of glaucoma, but it does not cross the blood-brain barrier as effectively as physostigmine. B) Edrophonium is a short-acting cholinesterase inhibitor primarily used for diagnostic purposes in conditions like myasthenia gravis, and it does not have the same blood-brain barrier penetration as physostigmine. C) Neostigmine is another cholinesterase inhibitor commonly used to treat conditions like myasthenia gravis and postoperative urinary retention, but it does not have the same central nervous system effects as physostigmine. In an educational context, understanding the pharmacokinetic properties of CNS drugs is crucial for healthcare professionals to make informed decisions when selecting appropriate treatments for patients. Knowledge of how different drugs interact with physiological barriers like the blood-brain barrier can impact treatment efficacy and potential side effects.
Question 3 of 5
A 67-year-old man with early onset of Alzheimer's disease is being seen by his primary care physician. Consideration is being made to begin preemptive therapy with an anticholinesterase inhibitor. The patient and family are made aware of such side effects as nausea, vomiting, diarrhea, and muscle cramps. The mechanism of action of these effects likely involves which of the following?
Correct Answer: B
Rationale: The correct answer is B) Cholinergic transmission. Anticholinesterase inhibitors work by inhibiting the enzyme acetylcholinesterase, which breaks down acetylcholine in the synaptic cleft. By inhibiting this enzyme, more acetylcholine is available for binding to cholinergic receptors, leading to increased cholinergic neurotransmission. The side effects mentioned in the question, such as nausea, vomiting, diarrhea, and muscle cramps, are typical of excess cholinergic activity. Option A) Adrenergic transmission is incorrect because anticholinesterase inhibitors do not directly modulate adrenergic neurotransmission. Option C) Purine metabolism impairment is unrelated to the mechanism of action of anticholinesterase inhibitors and is not responsible for the mentioned side effects. Option D) Transaminase enzyme elevation is also unrelated to the mechanism of action of anticholinesterase inhibitors and is not associated with the side effects described. In an educational context, understanding the mechanism of action of drugs is crucial for predicting their side effects and therapeutic effects. In this case, knowledge of how anticholinesterase inhibitors work provides insight into the side effects commonly associated with their use. This knowledge is essential for healthcare professionals when making decisions about drug therapy for patients with conditions such as Alzheimer's disease.
Question 4 of 5
A 38-year-old man with chronic anxiety and agitation is currently being treated with a long-acting benzodiazepine. He is having challenges with sleep and is referred to a sleep center for a 24-h sleep study to further ascertain his difficulties. Which of the following is the most likely abnormality to be noted on this study?
Correct Answer: B
Rationale: The correct answer is B) Hourly awakening from sleep. In this case, the patient is using a long-acting benzodiazepine for anxiety and agitation, which can lead to sleep disturbances such as frequent awakenings. Benzodiazepines, although they may aid in sleep initiation, can disrupt the architecture of sleep by reducing slow-wave sleep and increasing awakenings during the night. Option A) Calming effect during sleep induction is incorrect because benzodiazepines may induce initial sedation but can disrupt sleep architecture later in the night. Option C) Hypnotic effect with dreams is incorrect as benzodiazepines are not typically associated with vivid dreams but rather with disturbances in sleep continuity. Option D) Improved slow-wave sleep is incorrect because benzodiazepines are known to decrease slow-wave sleep. In an educational context, understanding the effects of CNS drugs on sleep architecture is crucial for healthcare professionals to effectively manage patients with sleep disturbances related to medication use. This question highlights the importance of recognizing the potential adverse effects of benzodiazepines on sleep patterns and the need for further evaluation in patients experiencing sleep disturbances.
Question 5 of 5
A 21-year-old college student is brought to the emergency department by his roommate after getting high on LSD after receiving a poor grade on a final examination. Physical examination by the triage nurse is performed. Which of the following findings would be expected in this patient?
Correct Answer: D
Rationale: In this scenario, the correct answer is D) Piloerection. LSD, a hallucinogenic drug, can lead to sympathetic nervous system activation, which causes piloerection (goosebumps) due to increased adrenaline release. This physiological response is commonly seen with psychedelic drug use. Option A) Constricted pupils is incorrect because LSD typically causes dilated pupils, known as mydriasis, due to its effects on serotonin receptors. Option B) Hypotension is unlikely as LSD tends to cause increases in blood pressure and heart rate rather than hypotension. Option C) Hypothermia is also unlikely as LSD can lead to increased body temperature and sweating due to its effects on thermoregulation. Educationally, understanding the physiological effects of psychoactive drugs like LSD is crucial for healthcare professionals to provide appropriate care and interventions for individuals experiencing drug-related emergencies. Recognizing these signs and symptoms can aid in prompt and effective management of patients in such situations.